Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Audited Standalone And Consolidated Financial Results Under Ind AS For The Quarter And For The Financial Year Ended 31St March, 2020

 With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. June 5, 2020, has taken on record and approved the Audited Standalone and Consolidated Financial Results of the Company under Ind AS for the quarter and for the year ended 31st March, 2020 and approved the following matters.
05-06-2020
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In continuation to our letter dated May 30th, 2020 regarding the Date and Notice of Board Meeting, please find enclosed the copies of the newspaper advertisements as appeared on May 31st, 2020 in Andhra Prabha (Telugu) and today i.e. June 01st, 2020 in Business Standard. The above information will also be hosted on the website of the Company at: http://www.suven.com/newspaperads.aspx This is for your information and record.
01-06-2020
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Intimation for To Consider And Approve The Audited Financial Results (Standalone And Consolidated) Of The Company Under Ind AS For The Fourth Quarter And Year Ended 31St March, 2020 And Related Matters.

 SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2020 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Friday, the 05th June, 2020 at 11:30 a.m. at the Registered Office of the Company at SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad-500034, to consider, among other things, inter alia, and take on record the following matter(s): To consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the fourth quarter and year ended 31st March, 2020 and related matters. Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from 01st April, 2020 as per PIT Code of the Company. Trading window will be opened from 8th June, 2020. You are requested to take this notice on your record.
30-05-2020
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Update On Intimation Of Fire Incident Occurred On 26Th April, 2020

 This is further to our intimation dated 27th April, 2020 about the fire incident in some of our R&D; labs situated in the premises of Suven Pharmaceuticals in Jeedimetla Unit, we hereby notify that damage to all the equipments, furniture & fixtures is estimated around Rs. 17 crores and were fully insured. There is no impact on the operations in Jeedimetla Unit. This is for your information and record.
29-04-2020
Bigul

Fire mishap at Suven Life Sciences unit in Hyderabad

 Fire broke out at Jeedimetla facility of drug maker Suven Life Sciences Ltd here on Sunday. Suven Pharmaceuticals experienced a fire incidence occur
27-04-2020
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Intimation Of Fire Incidence At Jeedimetla Unit In Hyderabad

 We wish to inform you that some of the labs of Suven Life Sciences located in Suven Pharmaceuticals premises, experienced a fire incidence occurred on April 26, 2020 in the evening at our Jeedimetla facility. Although there was damage to the labs in one of the building, there were no injuries or casualties. While the exact cause remains under investigation, we know the fire started in one lab in one of the buildings. Fewer staff were on site because it was Sunday, but those that were present followed their training and were able to successfully contain the incident to one portion of that building only until the fire tenders arrived. As a result of the effectiveness of those safeguards and the decisive actions of our employees, the facility is still operational other than that building. Suven will provide additional updates when more information becomes available. This is for your information and record.
27-04-2020
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Credit Rating

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to intimate you that the CRISIL Ratings removed from ''Watch Positive''; Ratings withdrawn of our Company vide its letter dated April 22, 2020: Facilities Rating Action Long-term Bank Facilities CRISIL A/Stable (Removed from ''Rating Watch with Positive Implications''; Rating Withdrawn) Short-term Bank Facilities CRISIL A1 (Removed from ''Rating Watch with Positive Implications''; Rating Withdrawn) This is for your information and record.
23-04-2020
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Investor Complaints For The Quarter Ended March 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 016151 Name of the Signatory :- Shrenik SoniDesignation :- Company Secretary and Compliance Officer
21-04-2020
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Shareholding for the Period Ended March 31, 2020

 Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
15-04-2020
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Half-Year Ended 31St March, 2020

 With reference to the above subject, please find enclosed Compliance Certificate for the half-year ended 31st March, 2020 duly signed by the Compliance Officer and authorized representative of the Share Transfer Agent i.e. KFIN Technologies Private Limited, Hyderabad (formerly known as Karvy Fintech Pvt. Ltd.), under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We request you to take this document on your record.
13-04-2020
Next Page
Close

Let's Open Free Demat Account